Günay, S. (2023) “Risk factors for the development of interstitial lung disease following severe COVID-19 pneumonia and outcomes of systemic corticosteroid therapy: 3-month follow-up: Interstitial lung disease following severe COVID-19 pneumonia”, Sarcoidosis, Vasculitis and Diffuse Lung Diseases, 40(3), p. e2023029. doi:10.36141/svdld.v40i3.14418.